Inside Eli Lilly's fight against counterfeit drugs

Eli Lilly and Company says 'obesity is a matter of health'

Fármaco para adelgazar reduciría el riesgo de desarrollar diabetes, según ensayos clínicos

Eli Lilly is a 'play' in type 2 diabetes and obesity: Sam Waksal

Eli Lilly stock tumbles on Q3 miss, Zepbound sales fall short

Four Biotech Stocks Rally Toward Buy Points As Funds Load Up

Eli Lilly stock pops: Wegovy beats Novo Nordisk rival drug in study